Colesevelam for type 2 diabetes mellitus (Q24202334)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

title

Colesevelam for type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Seng Cheong Loke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

12 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

CD009361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

The burden and costs of chronic diseases in low-income and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Standards of medical care in diabetes--2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Standards of Medical Care in Diabetes—2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

The economic burden of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Endocrine functions of bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Safety considerations with gastrointestinally active lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Inadequate treatment of dyslipidemia in people with type 2 diabetes: quality assessment of diabetes care in a Danish County

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

The case of the misleading funnel plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Sulfonylurea induced beta-cell apoptosis in cultured human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Use of the equivalence approach in reproductive health clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Regulation of bile acid synthesis by fat-soluble vitamins A and D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Investigating and Dealing with Publication and Other Biases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

The socioeconomics of diabetes from a developing country: a population based cost of illness study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Global healthcare expenditure on diabetes for 2010 and 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects

21 January 2018

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study.

1 reference

12 December 2020

Colesevelam HCl: a non-systemic lipidaltering drug

1 reference

12 December 2020

Bile acid salt binding with colesevelam HCl is not affected by suspension in common beverages

1 reference

12 December 2020

Burden of diabetes in the adult Chinese population: A systematic literature review and future projections

1 reference

12 December 2020

Epidemiology and costs of diabetes

1 reference

12 December 2020

Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study

1 reference

12 December 2020

Absorption, distribution and excretion of GT31-104, a novel bile acid sequestrant, in rats and dogs after acute and subchronic administration

1 reference

12 December 2020

Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009361.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD009361.PUB2

2 references

Consolidated OpenCitations Corpus – April 2017

2455935

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2455935

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

23235674

2 references

Consolidated OpenCitations Corpus – April 2017

2455935

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235674%20AND%20SRC:MED&resulttype=core&format=json